|
PPP2CB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.20620000000094E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.766400E-04 |
| Normal-vs-Stage2 |
6.460600E-03 |
| Normal-vs-Stage3 |
8.417800E-02 |
| Normal-vs-Stage4 |
3.979800E-02 |
| Stage1-vs-Stage2 |
9.589800E-01 |
| Stage1-vs-Stage3 |
4.214600E-01 |
| Stage1-vs-Stage4 |
6.552400E-01 |
| Stage2-vs-Stage3 |
4.652800E-01 |
| Stage2-vs-Stage4 |
5.771800E-01 |
| Stage3-vs-Stage4 |
2.782400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.94510000000637E-05 |
| Normal-vs-AfricanAmerican |
4.764700E-03 |
| Normal-vs-Asian |
6.231800E-02 |
| Caucasian-vs-AfricanAmerican |
6.876800E-01 |
| Caucasian-vs-Asian |
2.822600E-01 |
| AfricanAmerican-vs-Asian |
1.863230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.83840000000424E-05 |
| Normal-vs-Female |
9.750000E-04 |
| Male-vs-Female |
9.273800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.353200E-04 |
| Normal-vs-Extreme_Weight |
2.758700E-04 |
| Normal-vs-Obese |
1.160200E-01 |
| Normal-vs-Extreme_Obese |
1.323850E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.893200E-01 |
| Normal_Weight-vs-Obese |
1.654360E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.020200E-01 |
| Extreme_Weight-vs-Obese |
1.630810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.910400E-01 |
| Obese-vs-Extreme_Obese |
1.755810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.559600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.904700E-03 |
| Normal-vs-Age(61-80Yrs) |
4.11099999997333E-06 |
| Normal-vs-Age(81-100Yrs) |
1.088290E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.337000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.297150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.975600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.091170E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.085200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.402400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85353999999638E-05 |
| Normal-VS-Type2 PRCC |
4.244400E-02 |
| Normal-VS-KIRP CIMP |
1.493810E-01 |
| Normal-VS-Unclassified PRCC |
8.576400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.240800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.546800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.487400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.958400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.650800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.500000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.435300E-04 |
| Normal-vs-N1 |
3.881900E-02 |
| Normal-vs-N2 |
7.276200E-01 |
| N0-vs-N1 |
5.583400E-01 |
| N0-vs-N2 |
5.267600E-01 |
| N1-vs-N2 |
7.398200E-01 |
|
|
